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a b s t r a c t
A novel monopolar electroporation system and methodologies were developed for in vivo electroporation
intended for potential clinical applications such as gene therapy. We hypothesized that an asymmetric
anode/cathode electrode applicator geometry could produce favorable electric fields for electroporation,
without the typical drawback associated with traditional needle and parallel plate geometries. Three
monopolar electrode applicator prototypes were built and tested for gene delivery of reporter genes to
the skin in a guinea pig model. Gene expression was evaluated in terms of kinetics over time and expres-
sion distribution within the treatment site. Different pulsing parameters, including pulse amplitude,
pulse duration, and pulse number were evaluated. Monopolar gene electrotransfer significantly enhanced
gene expression compared to controls over the course of 21 days. Gene expression distribution was
observed throughout the full thickness of the epidermis, as well as notable expression in the deeper lay-
ers of the skin, including the dermis, and the underlying striated muscle without any damage at the treat-
ment site, which is a substantial improvement over previously reported expression confined to the
epidermis only. Expression distribution observed is consistent with the electric field distribution model,
indicating that our novel electrode geometry results in targeted electroporation and gene transfer. This is
important, as it may facilitate translation of many electroporation-based clinical therapies including gene
therapies, IRE, and ECT.
 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Electroporation in vivo is a technique to induce temporary (re-
versible) or permanent (irreversible) permeabilization of cell
membranes in various tissues. Electroporation in vivo is used for
several applications. Reversible electroporation is primarily used
for molecule delivery to the cells, such as plasmid DNA, RNA, or
chemotherapeutic drugs [1]. Irreversible electroporation (IRE) is
used for ablating tissue such as tumors [2], or asynchronized car-
diac cells to reduce arrhythmia [3]. Gene electrotransfer (GET), a
form of reversible electroporation, is a gene delivery method to
various mammalian tissues in vivo. This method uses pulsed elec-
tric fields acting on cell membranes to facilitate genetic material
transfer from the interstitial space outside the cells to inside the
cells and inside cell nuclei. The use of pulsed electric fields allows
for introduction of genetic material into the cells, without the use
of other vectors [4]. Most prominent gene delivery vehicles are
based on viral vectors, which carry inherent risks, including inte-
gration and immunogenicity. A commonly acknowledged disad-
vantage of electrotrasfer-mediated delivery is low gene
expression efficiency compared to viral methods, although few
studies have compared gene delivery efficiency directly. Gene
expression levels are typically modulated empirically by control-
ling electrotransfer parameters such as applied voltage, pulse dura-
tion, pulse polarity, interval duration, number of pulses and
electric field strength. Tissue conductivity is anisotropic and varies
between different parts of the body; therefore, specific electro-
transfer protocols are empirically tailored to the particular tissues
of interest. Early electrode applicator geometry used in vivo for
gene delivery, were needle arrays [5] and parallel plates [6]. These
geometries incorporate a cathode and an anode in a symmetrical
configuration with the site of electroporation targeted immedi-
ately between the two poles. These electrode geometries with
minor changes have persisted over the years, with the majority
of innovation focused on the pulsing parameters. Electroporation
https://doi.org/10.1016/j.bioelechem.2021.107814
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devices used for clinical applications are based on these two
geometries with two prominent examples being the MedPulser 
(Inovio, San Diego, CA) and the Cliniporator Vitae (IGEA SpA,
Carpi, Modena, Italy) used primarily for electro-chemotherapy
(ECT).
Parallel plate or caliper electrode applicators offer a relatively
uniform electric field distribution between symmetric cathode
and anode (BTX, Holliston, MA). The benefit of a uniform electric
field is that the majority of the cells within the treatment site are
exposed to the same electric field during pulses as the neighboring
cells within the treatment site. Therefore, if optimal electric field
strength, pulse number and pulse duration are determined, the
majority of the cells within the treatment site will see the same
conditions and become electroporated in the same way. The draw-
back of this electrode applicator geometry is that a relatively small
distance between the plates is required to achieve a uniform elec-
tric field. In practice, tissue of interest has to often be pinched and
folded between the plates to fit into a small space, which is not
always possible. For application where it is important that the
entire treatment site is uniformly electroporated, (ex. Tumor treat-
ment for ECT, IRE, or GET) missing a piece of tissue because it will
not fit between the parallel plates is a problem.
The needle electrode applicator geometry (Fig. 1A) minimizes
the problem of compressing tissue between the cathode and the
anode, at the expense of electric field homogeneity as well as the
non-invasive nature of the applicator. Needle arrays consisting of
pairs of cathodes and anodes, must be inserted into the tissue of
interest for delivery of optimal electric field distribution. Inherent
to this geometry, the resulting electric field is extremely heteroge-
neous. Near the needles the electric field can be more than10 fold
higher than at the midpoint between the needles. This electric field
distribution (Fig. 1B), while effective at gene delivery in some loca-
tions within the treatment site, also has regions that are exposed to
extremely high and extremely low electric fields. Fig. 1 shows an
example of an electric field distribution in an isotropic material
with a four-needle electrode applicator geometry. The electric field
adjacent to each needle is 421 V/cm and drops below 40 V/cm
between the needles with an applied voltage of 50 V. In compar-
ison, a parallel-plate electrode geometry would yield a uniform
100 V/cm electric field with the same applied voltage and the same
distance between the electrodes. Therefore, tissues treated with
needle electrode applicator geometries may be subjected to dam-
age near the needles, or insufficient electroporation farther away
from the needles. Needles inserted into tissue cause mechanical
damage and carry the risk of excessive bleeding if they puncture
a blood vessel.
Another prominent example of non-invasive electrode geome-
try is the multi-electrode array (MEA) [7]. It was first described
for gene delivery to the skin, with a 4x4 non-penetrating pin con-
figuration and a unique pulsing sequence activating only 4 pins per
pulse (2 cathodes and 2 anodes 2 mm apart) and repeating with
Fig. 1. Electric field distribution for bipolar and monopolar electrode applicator geometries. An applied voltage of 50 V was used for both models. An example of a four-
needle electrode with a 5 mm gap typically used for gene delivery is shown in (A). The corresponding electric field distribution is shown in (B). A prototype 10 mmmonopolar
electrode is shown in (C). The schematic of the circuit diagram for monopolar electroporation, shows a small active electrode, and a large ground electrode and a pulse
generator to complete the circuit (D). The electric field distribution at the 10 mm, active electrode is shown in the x-z plane in (E) and the x-y plane in (F), the electric field at
the ground electrode is negligible in magnitude and is therefore not shown.
Fig. 2. Monopolar GET to skin significantly enhances plasmid DNA encoding
luciferase delivery and expression as observed on day 2 (p < 0.0254).
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the next set of electrodes within the array, until all electrodes have
fired, up to 72 pulses for the 4x4 arrangement [7]. During each
pulse the electric field is similar to the electric field induced by
the needle electrodes, with the same symmetric, bipolar configura-
tion. Unique elements about this electrode are the pulsing
sequence and ability to activate individual pins independent of
other pins within the array, which allows for a small gap between
pairs of electrodes and coverage of a larger surface area. Further
variations of this electrode have been reported [8,9]. Gene expres-
sion has been largely confined to the epidermis [8–11], due to
heterogeneity of the electric field and low penetration into deeper
tissue layers.
In the current study, a new electroporation system and method-
ology were investigated with the focus on the electrode applicator
geometry. The electrode applicator geometry was designed to have
the advantages of caliper and needle electrodes without the asso-
ciated drawbacks. The new non-penetrating geometry allows for
uniform electric field coverage of a desired treatment site, without
tissue deformation or needle insertion. This monopolar geometry
can be used in a non-invasive or minimally invasive configuration,
delivering electroporation, without unintended damage to the
treatment site or other distant sites. We believe this novel
approach has the potential to improve gene transfer to the skin
in vivo. While the current study focuses on skin the principles
described here apply to broader electroporation applications such
as gene transfer, electrochemortherapy, and irreversible electropo-
ration to various tissues within the body including skin, tumors,
muscle, liver, kidney, heart and brain.
2. Methods
2.1. Monopolar electrode applicator design
The electric field distribution resulting from a monopolar elec-
trode applicator geometry (Fig. 1D) was modeled using COMSOL
Multiphysics Modeling Software assuming an electrically isotro-
pic material (Fig. 1E-F). Significant asymmetry between the surface
area of the cathode and anode, results in dispersed/negligible fields
at the larger electrode, and high electric field strengths at the site
of the smaller electrode. We, therefore, hypothesized that shapes
and dimensions of the active (small electrode) and non-active (lar-
ger) return electrode could be determined that result in favorable
electroporation conditions at the active electrode, with minimal
effects at the return electrode. Fig. 1E shows an example of electric
field distribution showing a 10 mm in diameter flat electrode, with
a 10X larger return electrode at a distant site, applied to an
isotropic material. The applied voltage of 50 V was chosen as a typ-
ical applied voltage used for gene delivery to the skin with elec-
trodes such as calipers and MEA. This modeling was performed
to gain a better understanding of the gene delivery and expression
that was observed in deeper layers of the skin and the underlying
muscle (Fig. 3). We built three prototype electrodes, 6 mm, 10 mm
and 12 mm conductive disks (Fig. 1C). The return electrode was
kept the same as a 100 cm2 conductive plate.
2.2. Animals
Female Hartley guinea pigs weighing approximately 250–300 g
were used for this study. All experimental studies followed an
approved Old Dominion University’s Institutional Animal Care
and Use Committee protocol, in accordance with the Guide for the
Care and Use of Laboratory Animals at an AAALAC-accredited facil-
ity. Guinea pigs were allowed to acclimate for seven days prior
to experimental studies.
2.3. Plasmid
Firefly luciferase encoding plasmid DNA, gWiz-Luc, was pur-
chased from Aldevron (Fargo, ND). Plasmid DNA encoding firefly
luciferase tagged with a DDK tag, gWiz-Luc-DDK, was prepared
for expression distribution studies. To construct gWiz-Luc-Myc-
DDK, the sequence encoding luciferase from gWiz-Luc (Genlantis,
San Diego, CA, USA) followed by an in frameMyc-DDK tag was arti-
ficially synthesized and cloned into pBluescript II SK(+) (Biomatik,
Wilmington, DE, USA). For better expression comparison to the
parent plasmid, the sequences were not codon optimized. The
insert was then subcloned into gWiz-Blank (Genlantis, San Diego,
CA, USA).
DNA was suspended in sterile saline at 2 mg/ml and a Limulus
Amebocyte Lysate assay was performed by Aldevron to confirm
that endotoxin levels were < 0.1 EU/lg plasmid.
2.4. Gene electrotransfer procedure
Animals were anesthetized with isoflurane inhalation. Both
flanks were carefully shaved to remove as much hair as possible
to allow for direct electrode contact with the skin. The animals
were placed on their side, and the return plate electrode was
placed under the opposite flank with ultrasound gel applied
between the skin and grounding plate to ensure contact. A 50 lL
intradermal injection of plasmid DNA solution was administered
to the treatment site. Immediately after injection, the active
Fig. 3. Monopolar GET enhances gene delivery to skin. Gene expression is undetectable in untreated sites of the epidermis and dermis(A) and underlying muscle (F), Gene
expression is detected in the epidermis (B-E), dermis (red arrows in C and D), and underlying muscle (G-J). Scale bar is 20 lm, with a 400X magnification.
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No Treatment Control 6mm, 200V 6mm,400V 12mm, 200V 12mm,400V 
electrode was then centered on top of the injection site to ensure
contact and 8 pulses at 1 Hz were administered. Once electrotrans-
fer was completed the animals were allowed to recover from anes-
thesia. 6 mm, 10 mm, and 12 mm in diameter electrodes were
tested. Applied voltage of 200 V and 400 V was generated by the
ECM 830 Square Wave Electroporation System (BTX, Holliston,
MA) for pulse delivery. Control groups either received plasmid
DNA injection only without pulses or received 8-pulses at 50 V
with a four-pin bipolar MEA electrode4 at 3 Hz as a positive control.
2.5. Bioluminescence imaging
Bioluminescence imaging was performed on days 2, 7, 14, and
21. After isoflurane inhalation anesthesia induction animals
received intradermal injections of D-luciferin (Gold Biotechnology,
Inc., St. Louis, MO) at treatment sites. The In Vivo Imaging System
(PerkinElmer, Akron OH) was used to capture and quantitate biolu-
minescence signal. Groups were compared with an ordinary two-
way ANOVA, and Tukey’s multiple comparisons test, with
p < 0.05 considered significant.
2.6. Immunofluorescence and Brightfield analysis
Immunofluorescence (IF) staining for DDK tag protein was per-
formed to evaluate gene expression distribution within the treat-
ment sites. Skin samples were collected two days post gene
transfer, fixed in 4% paraformaldehyde, paraffin embedded and
sectioned to 6 lm sections by IDEXX Laboratories, Inc (Westbrook,
Maine). Hematoxylin and eosin staining was also performed on
serial sections by IDEXX Laboratories for inflammation and tissue
damage assessment. Unstained sections were deparaffinized in
CitriSolvTM, and rehydrated in gradient alcohol. Antigen retrieval
was performed in citric acid (pH6); sections were then stained
for immunoreactivity with DDK-tag protein with a mouse mono-
clonal anti-DDK antibody (TA50011-1, OriGene, Rockville, MD)
and labeled with an AlexaFluor488 conjugated goat anti-mouse
IgG secondary antibody (ThermoFisher Scientific, Grand Island
NY). Negative control samples were treated with secondary anti-
body only, without primary antibody. Fluorescence imaging was
performed with an upright Olympus fluorescence microscope, with
a DP70 cameral, with 40X and 20X objectives. All samples were
counterstained with DAPI for cell nuclei identification. Brightfield
imaging was performed with a Leica DMIL microscope, a
DFC7000 camera and a 20x objective.
3. Results and discussion
3.1. Electric field distribution
Modeling of the electric field distribution revealed that a typical
needle electrode geometry results in hot spots near the needles or
pins with lower values at the midpoint between the needles rang-
ing from 421 V/cm to 40 V/cm (lower outside of the 5x5mm2 treat-
ment area), shown in Fig. 1B, as expected. The monopolar electrode
geometry with a 10 mm in diameter active electrode, resulted in a
relatively homogenous electric field ranging from 50 V/cm to 35 V/
cm within a typical treatment site. The applied voltage was kept at
50 V for both geometries to enable a direct comparison. The opti-
mal electric field for gene delivery to the skin is unknown, however
partially due to the delivery of heterogeneous electric field config-
urations, as well as heterogeneous nature of conductivity within
biologic tissues. We therefore selected an applied voltage of
200 V as a starting point for our experiments, which according to
our electric field approximations would result in an electric field
of 200–140 V/cm, which supports enhanced expression seen at
the depth of 1–2 mm in our experimental studies.
3.2. Monopolar GET enhances luciferase expression at 48 h
The pilot experiments for in vivo monopolar GET to skin were
carried out with a 6 mm and a 12 mm in diameter monopolar elec-
trodes, with an applied voltage of 200 V and 400 V. Electrotransfer
parameters such as voltage, pulse duration, pulse frequency and
number were chosen based on previous studies conducted with
the bipolar four-pin MEA geometry and pulsing parameters, there-
fore, 150 ms, and 8 pulses were used. Pulse frequency was reduced
to 1 Hz from 3 Hz due to observation of twitching, which was min-
imized with the lower frequency pulses. As shown in Fig. 2,
monopolar GET did enhance gene expression of luciferase as mea-
sured by bioluminescence imaging on day 2. The applied voltage of
200 V with a 12 mm electrode resulted in significantly higher
expression compared to the control. While expression was
enhanced over negative controls, these levels (107-108p/s) are
lower than those reported for optimized GET delivery to the skin
with the MEA10, 11, therefore other pulsing conditions were tested
in experiments evaluating gene expression kinetics over time.
3.3. Monopolar GET enhances gene delivery to Epidermis, dermis and
muscle
DDK-tagged luciferase encoding plasmid DNA was delivered to
the skin using the 6 mm or 12 mmmonopolar electrode with 200 V
or 400 V applied voltage. As can be seen in Fig. 3, which shows
cross sections of treatment sites stained for the DDK-tag in green,
gene expression can be observed occupying much of the full thick-
ness of the epidermis and the underlying muscle for all pulsing
conditions, additionally also the dermis for some pulsing parame-
ters (marked with red arrows in Fig. 3B–C). Bipolar GET resulted in
a thin band of gene expression confined to the epithelium (Fig. 4B),
with no expression in the dermis, hypodermis, or the underlying
muscle consistent with previous reports by other groups. Gene
expression in the deeper layers of the skin, dermis, hypodermis
and underlying muscle have not been reported with bipolar GET
intradermal delivery methods. Some reports do claim expression
in deeper layers of the skin, however transfected cells are typically
found in the epidermis of hair follicles, and not dermal, hypoder-
mal, or muscle cells.
3.4. Epidermal gene expression distribution
The width of gene expression within the epidermis was com-
pared between the monopolar conditions and bipolar conditions.
Fig. 4A-B shows monopolar epidermal and bipolar epidermal
expression of DDK tag two days post GET. Width of expression
was measured using ImageJ software, and is shown in Fig. 4C. In
addition, to determine the proportion of the epidermis that was
successfully transfected the width of the epidermis per site was
measured from H&E sections serial to those that were stained for
the DDK tag. The serial sections were sample matched to ensure
controlling for anatomical variability in epidermal thickness. The
proportion of the epidermis that was transfected was significantly
higher with monopolar GET than bipolar GET, as shown in Fig. 4D
(p < 0.0001). Stratum basale, and stratum spinosum exhibit expres-
sion, at the sites that received monopolar GET, in contrast to bipo-
lar GET resulting in expression confined to the stratum basale.
Gene expression observed in multiple layers of the epidermis has
not been reported for bipolar GET methods.
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3.5. Monopolar GET enhances gene expression over time
Monopolar GET with different pulsing conditions was used to
deliver plasmid DNA encoding firefly luciferase to the skin. Biolu-
minescence imaging monitoring was performed over the course
of 21 days, as summarized in Fig. 5. It was determined that certain
pulsing parameters can significantly enhance gene delivery and
expression over the course of 21 days, as reported in Fig. 5B. A
10 mm in diameter applicator was used with an applied voltage
of 200 V, 150 ms and 8 pulses. These conditions resulted in a robust
>10 fold increase of gene expression over the injection only con-
trol. Gene expression kinetics were similar to those observed with
optimized bipolar GET methods previously reported in literature
[10,11].
4. Conclusion
While gene electrotransfer is an established research technol-
ogy for gene transfer in vivo for therapeutic applications such as
immunotherapy, cancer therapy, vaccines, wound healing, and
angiogenic therapies for ischemia [4,12–16], the technology has
Fig. 4. Monopolar GET efficiently enhances expression throughout epidermis. Examples of DDK-tag expression in the epidermis with monopolar (A) and bipolar (B) GET,
were used for measuring the depth of gene expression within the epidermis (n = 10). Corresponding H&E images of sample-matched serial sections (C-D) were used for
measuring the thickness of the epidermis (n = 10). The expression depth within the epidermis was significantly higher with monopolar GET compared to bipolar GET, when
measured directly or as a percent of the epidermal thickness (p < 0.0001). Scale bars are 50 lm, with a 200X magnification.
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focused on localized bipolar applicator geometries and methods.
The in vivo electroporation field has also largely focused on opti-
mizing parameters such as pulse width, pulse amplitude, and pulse
frequency, with little attention dedicated to the distribution of the
electric field, and the geometry of the applicators required to
achieve particular electric fields. Original bipolar geometries based
on needle electrodes or caliper electrodes, while effective at elec-
troporation and do enhance gene transfer, have a few disadvan-
tages. These disadvantages are rooted in the shape of the electric
field relative to the desired shape of the treatment site and cannot
be addressed by optimizing pulse widths, pulse amplitudes, fre-
quencies or pulse numbers. Changing the geometry of the pulsed
electric field can address challenges of electric field access to tis-
sues normally unapproachable by established bipolar methods. A
previously reported gene transfer study used a monopolar
approach for gene delivery to the thymus [17]. However the active
electrode was an invasive, penetrating needle, which was inserted
directly into the thymus, while the return electrode was an alliga-
tor clip, which due to its small size exposes tissue to a high electric
field at the non-treatment site17, proving no advantages over con-
ventional bipolar electroporation. Non-invasive, non-penetrating,
monopolar applicator geometries and associated methods investi-
gated in our current work, overcome disadvantages associated
with conventional bipolar geometries electroporation. As demon-
strated in this work with multiple reporter genes, gene delivery
and expression can be safely enhanced for gene delivery to the
skin. Monopolar electrotransfer was advantageous over routine
bipolar gene electrotransfer in multiple ways. While gene expres-
sion can be enhanced by both methods, the uniform electric field
produced by our monopolar electrodes resulted in no visible dam-
age to the skin at the applied voltage of up to 400 V. It is well doc-
umented that luciferase expression in the skin delivered with
optimized bipolar parameters can reach the order of 108-109pho-
tons per second on day 2 [4,10,11], however it is also well docu-
mented that expression is confined to the epidermis, specifically
the basal stratum of the epidermis [8–11]. Here, equivalent expres-
sion levels (~108.5p/s) were observed with only 8 pulses (compared
to 72 reported with the MEA [4,11]) in a treatment site of the
equivalent size (Fig. 5B), and no damage was observed. It is also
of note, that gene expression was observed as deep (~1.5 mm) in
the muscle layer underlying the skin. Expression in the dermis
and a much more efficient delivery to the epidermis, covering a
wider range of the epidermal strata were also observed. The signif-
icance of this work is proof-of-concept for a new method of elec-
troporation that may serve various applications. Optimization of
this method could result in efficient in vivo electroporation of dif-
ferent tissues for multiple medicinal applications, demonstrated
here with gene delivery via monopolar gene electrotransfer to
the skin.
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